Intestinal fructose absorption: clinical and molecular aspects.
about
Health implications of fructose consumption: A review of recent dataDietary and developmental regulation of intestinal sugar transportThe role and requirements of digestible dietary carbohydrates in infants and toddlersFructose Metabolism and Relation to Atherosclerosis, Type 2 Diabetes, and ObesityMetabolic fate of fructose ingested with and without glucose in a mixed meal.Arterial hypertension due to fructose ingestion: model based on intermittent osmotic fluid trapping in the small bowel.Sugar making sugar: gluconeogenesis triggered by fructose via a hypothalamic-adrenal-corticosterone circuitGlucose transporter 8 (GLUT8) regulates enterocyte fructose transport and global mammalian fructose utilization.Hexose transporter expression and function in mouse small intestine: role of diurnal rhythm.Nutrition management of chronic diarrhea and malabsorption.Coordinated, diurnal hexose transporter expression in rat small bowel: implications for small bowel resection.Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male miceIntestinal fructose transport and malabsorption in humans.Differences in acute metabolism of fructose between hemodialysis patients and healthy subjects.The active and passive components of glucose absorption in rat jejunum under low and high perfusion stress.Opinion of the Scientific Panel on Dietetic products, nutrition and allergies [NDA] related to the evaluation of fructose for labelling purposesRecent insights into the role of ChREBP in intestinal fructose absorption and metabolism
P2860
Q21245059-1961B7AE-1E00-4E94-A418-58BA19F0E4BDQ24533525-C5E91220-E8AE-41BB-A0F2-FD0CF2FB1C9CQ24633572-4C6B1105-8138-4110-B0A4-0C0937DC237CQ26801099-A714EA19-40FA-4AEC-8B7C-A2411697427EQ33963267-2723F44E-C5AC-4F7C-86FD-BCDF483EA99EQ33995679-F8A7EDB4-25C0-43F6-8EFD-5F268FED4FDBQ36113952-C7721C10-CA7B-42E1-8F74-7D934C7FE3D1Q36177375-51146F12-2DB3-4F59-8F0F-9D0C09324C9DQ36186877-4F6247B6-8712-4B27-BDD5-CE10F4967E42Q36378740-EA5B4337-1AD6-48BB-9E12-5BC78E936E82Q36405129-604642CE-FE9D-464C-914C-FF19174BF189Q37249085-52ACE33A-0B90-4FC8-B723-0116A3D61CB7Q37819514-BA4820AB-DA2E-48A5-90F7-E8312F234BD8Q42278021-F7E23113-1723-4BAE-B680-6EAE0FF3E2C5Q44180922-5BCFEE10-35AD-4F52-8DB0-570BBDD71737Q47143717-0CFA4177-9EF9-4BF2-B582-5CC8B859CB8FQ58795278-A1D357DF-8EFC-461D-948B-55256C8D406F
P2860
Intestinal fructose absorption: clinical and molecular aspects.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Intestinal fructose absorption: clinical and molecular aspects.
@ast
Intestinal fructose absorption: clinical and molecular aspects.
@en
type
label
Intestinal fructose absorption: clinical and molecular aspects.
@ast
Intestinal fructose absorption: clinical and molecular aspects.
@en
prefLabel
Intestinal fructose absorption: clinical and molecular aspects.
@ast
Intestinal fructose absorption: clinical and molecular aspects.
@en
P1476
Intestinal fructose absorption: clinical and molecular aspects
@en
P2093
J H Hoekstra
P304
P356
10.1097/00005176-199904000-00004
P407
P577
1999-04-01T00:00:00Z